INHBE and melanoma: Our analysis of a publicly available sequencing dataset is in concordance with prior studies, which have consistently supported the prognostic utility of both serum and tissue activin expression across multiple cancer types, including lung, breast, colorectal, pancreatic and melanoma.17, 21, 25